arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Sarepta Therapeutics, Inc.

SRPT

$16.77 ▼ -0.01 (-0.03%) at close

19 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

Sarepta Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $1.7B

Dividend Yield —

Revenue Growth 15.6% ↘

Op. Margin -31.8% ↘

ROIC -55.5% ↘

FCF / Share $-3.07 ↗

Trailing P/E —

Price / Book 1.5x

FCF Yield —

Debt / Equity 0.12

info Valuation on last close. End-of-day price, Aug 7, 2026.

19-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.20B

↑ +15.6% —

Net Income Profit after all expenses

$-713.41M

↓ -403.3% —

Operating Margin Operating profit as % of sales

-31.8%

↓ -377.6% 7th

FCF / Share Free cash flow per share

$-3.07

↑ +14.8% —

Long-Term Debt Long-term obligations

$140.50M

↓ -87.6% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Revenue Growth YoY (%)	15.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+95%)	53.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+562%)	33.3% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+316%)	32.9% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+312%)	30.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+274%)	41.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+423%)	26.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+231%)	94.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1084%)	2751.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+34295%)	332.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4058%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	N/M	27.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-55.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	-7.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	N/M	N/M	23.8% Good ↑ Good Improving Year-over-year change in net income	-68.0% Weak ↓ Weak Declining Year-over-year change in net income	24.4% Good ↑ Good Improving Year-over-year change in net income	22.5% Good ↑ Good Improving Year-over-year change in net income	-97.6% Weak ↑ Weak Improving Year-over-year change in net income	-614.0% Weak ↓ Weak Declining Year-over-year change in net income	81.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-21.5% Weak ↓ Weak Declining Year-over-year change in net income	-62.0% Weak ↑ Weak Improving Year-over-year change in net income	75.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-26.0% Weak ↑ Weak Improving Year-over-year change in net income	-18504.4% Weak ↓ Weak Declining Year-over-year change in net income	92.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-27.9% Weak Weak Year-over-year change in net income	89.9% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	14.8% Fair ↑ Fair Improving Year-over-year change in free cash flow	42.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-53.5% Weak Weak Year-over-year change in free cash flow	31.4% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	-3.3% Weak Weak Year-over-year change in free cash flow	-63.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	13.6% Fair ↑ Fair Improving Year-over-year change in free cash flow	-930.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	-33.3% Weak Weak Year-over-year change in free cash flow	-38.0% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	33.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	39.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	32.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	34.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	32.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	312.6% Excellent Excellent Compound annual revenue growth over 3 years	521.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	32.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	37.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	32.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	43.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	164.5% Excellent Excellent Compound annual revenue growth over 5 years	236.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Operating Margin (%) (%)	-31.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-312%)	11.5% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-24%)	-21.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-244%)	-57.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-483%)	-65.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-537%)	-104.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-796%)	-185.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1335%)	-114.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-861%)	-111.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-840%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-1.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	9.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-32.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-370%)	12.4% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	-43.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-459%)	-75.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-728%)	-59.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-597%)	-102.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-955%)	-187.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1665%)	-120.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1102%)	-32.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-373%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-14.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-18.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-46.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-38.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-68.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	4.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-135.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-149.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-157.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.43x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	4.81x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	10.72x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Return on Invested Capital (%)	-55.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.4% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-74.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-91.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-143.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-227.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	1696.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-20.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.5% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-62.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-80.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-154.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-175.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-45.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-62.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-517%)	15.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-62.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-516%)	-182.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1318%)	-45.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-72.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-585%)	-87.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-683%)	-35.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-334%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-79.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-629%)	-115.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-871%)	-54.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-466%)	-219.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1565%)	—	-7.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Debt to Equity (x)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.74x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+24%)	1.44x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+140%)	4.01x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+569%)	0.61x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	—	—	0.41x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-32%)	0.55x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-9%)	—	—	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-91%)	-0.65x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-209%)	—	—	—
Interest Coverage (x)	-18.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	11.86x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-12.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.01x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-29.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-140.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-1337.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4509.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4193.81x Weak Weak Operating income divided by interest expense Optimal: > 5x	-399.19x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-660.78M	$34.11M	$809.57M	$577.51M	$-1.55B	$-1.50B	$-835.08M	$49.73M	$-168.64M	$-122.42M	$-80.30M	$-66.45M	$-255.30M	$-185.90M	$-38.15M	$-31.75M	$-48.27M	$-11.19M	$0.00
Debt / EBITDA (x)	-0.21x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	4.45x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-5.54x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.12x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.34x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-1.27x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.64x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.05x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Revenue per Share (USD)	$21.96	$20.01	$13.46	$10.66	$8.64	$6.93	$5.17	$4.54	$2.63	$0.11	$0.03	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-7.13	$2.47	$-5.80	$-8.03	$-5.15	—	—	—	—	—	—	—	—	—	—	$-1.74	$-1.62	—	—
Free Cash Flow per Share (USD)	$-3.07	$-3.60	$-6.25	$-4.07	$-5.93	$0.32	$-7.01	$-6.79	$-4.15	—	—	—	$-10.25	$-11.86	$-1.15	$-0.86	$-0.63	—	—
Book Value per Share (USD)	$10.87	$15.77	$9.17	$4.38	$10.65	$9.60	$10.88	$14.52	$12.18	$6.15	$4.17	$5.99	$6.55	$3.90	$1.37	$-0.15	—	—	—
Tangible Book Value per Share (USD)	$10.87	$15.77	$9.17	$4.38	$10.65	$9.60	$10.88	$14.52	$12.18	$6.15	$4.17	$5.99	$6.55	$3.90	$1.37	$-0.15	—	—	—
Basic Weighted Avg Shares (shares)	100.12M	95.08M	92.40M	87.56M	81.26M	77.96M	73.61M	66.25M	58.82M	48.70M	42.29M	40.03M	33.85M	23.60M	21.60M	18.58M	15.55M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Working Capital (USD)	$1.44B	$2.34B	$1.93B	$1.94B	$2.15B	$2.07B	$1.20B	$1.25B	$1.14B	$298.05M	$162.25M	$210.93M	$234.84M	$115.02M	$24.58M	$-8.02M	—	—	—
LT Debt (USD)	$140.50M	$1.14B	$1.24B	$1.54B	$563.67M	—	—	$420.55M	$431.05M	—	—	$7.10M	$1.67M	$1.76M	$1.76M	$1.84M	—	—	—
Total Equity (USD)	$1.14B	$1.53B	$859.34M	$384.95M	$928.01M	$761.76M	$818.19M	$1.03B	$789.22M	$336.69M	$190.35M	$247.65M	$247.19M	$123.68M	$31.02M	$-2.82M	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 1980 Jul 21, 1980 10-K ↗
Sales/Revenue/Turnover (USD)	$2.20B	$1.90B	$1.24B	$933.01M	$701.89M	$540.10M	$380.83M	$301.03M	$154.58M	$5.42M	$1.25M	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$44.52M	$37.72M	$44.40M	$41.86M	$38.02M	$26.91M	$24.50M	$12.24M	$8.09M	$5.61M	$5.25M	$3.69M	$23.25M	$21.97M	$1.30M	$1.46M	$1.38M	—	—
Net Income, GAAP (USD)	$-713.41M	$235.24M	$-535.98M	$-703.49M	$-418.78M	$-554.13M	$-715.08M	$-361.92M	$-50.69M	$-267.26M	$-220.03M	$-135.79M	$-543.24M	$-431.25M	$-2.32M	$-32.18M	$-25.16M	$-250.31M	—
Operating Cash Flow (USD)	$-205.48M	$-205.79M	$-500.99M	$-325.35M	$-443.17M	$107.47M	$-456.46M	$-388.66M	$-232.00M	—	—	—	$-324.60M	$-259.91M	$-23.68M	$-15.21M	$-8.80M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 69 quarters

Sarepta Therapeutics, Inc.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SRPT with peers